PGEN

NASDAQ · Biotechnology

Precigen Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.13

+0.22 (+3.18%)

As of Aug 8, 1:40 AM ET ·

PGEN News1 articles

Precigen Surges on Papzimeos Revenue, Narrows Loss in Q1

Precigen (PGEN) shares surged 14% as Q1 revenue of $23.3M beat estimates, fueled by $21.6M from Papzimeos. Net loss narrowed to $7.9M from $54.2M a year ago.

Earnings May 14